Status | Study |
Completed |
Study Name: BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors Condition: Breast Cancer Endometrial Cancer Head and Neck Cancer Date: 2007-09-05 Interventions: Drug: BI 2536 Other: high performance liqu |
Not yet recruiting |
Study Name: Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer Condition: Advanced Ovarian Carcinoma Primary Peritoneal Carcinoma Date: 2007-08-03 Interventions: Drug: Avastin Initial Treatment: |
Completed |
Study Name: Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer Condition: Fallopian Tube Cancer Ovarian Cancer Primary Peritoneal Ca Date: 2007-06-06 Interventions: Biological: bevacizumab Drug: carboplatin |
Completed |
Study Name: Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma Condition: Fallopian Tube Cancer Female Reproductive Cancer Date: 2006-10-18 Interventions: Drug: ziv-aflibercept Given IV Other Names: |
Completed |
Study Name: Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer Condition: Fallopian Tube Carcinoma Infectious Disorder Neutropenia Date: 2006-07-13 Interventions: Procedure: Adjuvant Therapy Drug: Carbopla |
Completed |
Study Name: Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) Condition: Brenner Tumor Fallopian Tube Cancer Date: 2004-06-10 Interventions: Drug: carboplatin Given intrap |
Completed |
Study Name: Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors Condition: Cervical Cancer Fallopian Tube Cancer Head and Neck Cancer Date: 2003-08-06 Interventions: Biological: SS1(dsFv)-PE38 immunotoxin |
Completed |
Study Name: Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer Condition: Cervical Cancer Endometrial Cancer Fallopian Tube Cancer Date: 2002-03-08 Interventions: Drug: carboplatin AUC 6 q4w |
Completed |
Study Name: Immunotoxin Therapy in Treating Patients With Advanced Cancer Condition: Cervical Cancer Fallopian Tube Cancer Head and Neck Cancer Date: 2000-12-06 Interventions: Biological: SS1(dsFv)-PE38 immunotoxin |
Completed |
Study Name: Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract Condition: Endometrial Cancer Fallopian Tube Cancer Ovarian Cancer Date: 1999-11-01 Interventions: Drug: paclitaxel Drug: pegylated liposomal |